Novo Nordisk AS Newswire

Novo Nordisk AS Newswire

Comprehensive Real-Time News Feed for Novo Nordisk AS.

Results 1 - 20 of 966 in Novo Nordisk AS

  1. How To Research And Invest In Global Stocks The Smart WayRead the original story w/Photo

    19 hrs ago | Seeking Alpha

    With the chart above being so scary, especially when that data is backed up by recent news of slowing U.S. GDP , it is no wonder that smart investors are turning more and more to global investing trying to diversify outside of the U.S. These same investors unfortunately are becoming confused, as high quality research in this area has been hard to get one's hands on unless one is willing to pay up for the privilege. In order to help these investors, we at Friedrich Global Research have brought our conservative, high-quality global research to Seeking Alpha's Market Place and have priced it at a fraction of what a FactSet, Capital IQ, Thomson Reuters or Bloomberg service would cost.

    Comment?

  2. Dillon & Associates Inc. Purchases 5,765 Shares of Novo Nordisk A/SRead the original story w/Photo

    Friday | Daily Political

    Dillon & Associates Inc. raised its stake in shares of Novo Nordisk A/S by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 146,772 shares of the company's stock after buying an additional 5,765 shares during the period.

    Comment?

  3. Novo Nordisk has been accused of engaging in a 'white coat...Read the original story w/Photo

    Friday | Greenwich Citizen

    Danish pharmaceutical giant Novo Nordisk is being accused of engaging in a "white coat marketing scheme" to entice doctors to prescribe three of its diabetes drugs - NovoLog, Levimir, and Victoza. Together these three drugs made Novo Nordisk $6 billion in sales in 2013, comprising 10% of the company's worldwide sales for the year, according to the complaint.

    Comment?

  4. Novo Nordisk Accused of Illegally Marketing Diabetes DrugsRead the original story w/Photo

    Friday | Bloomberg

    Novo Nordisk A/S has been accused of illegally marketing its diabetes drugs by disguising salespeople as medical educators and using giveaways to persuade doctors to prescribe its medicines. Victoza diabetes drug that were covered by federal health-insurance programs, two whistle-blowers said in a lawsuit unsealed Thursday.

    Comment?

  5. Novo Nordisk A/S (NVO) Receives Daily News Impact Rating of 0.16Read the original story w/Photo

    Friday | IntersportsWire

    News articles about Novo Nordisk A/S have trended somewhat positive this week, according to AlphaOne. AlphaOne, a unit of Accern, identifies negative and positive press coverage by analyzing more than 20 million news and blog sources.

    Comment?

  6. Current TradesRead the original story w/Photo

    Thursday | Seeking Alpha

    This week has been progressing nicely, although I have to laugh at the surge in global equity prices and the sharp drop gold/silver miners, following the French election. Populism is still strong, and politicians are doing stupid things.

    Comment?

  7. Novo Nordisk A/S (NVO) Stake Increased by Parsec Financial Management Inc.Read the original story w/Photo

    Thursday Apr 27 | Daily Political

    Parsec Financial Management Inc. raised its position in Novo Nordisk A/S by 35.7% during the first quarter, Holdings Channel reports. The fund owned 341,245 shares of the company's stock after buying an additional 89,808 shares during the period.

    Comment?

  8. Photos: Pinewoods kids receive new bikesRead the original story

    Thursday Apr 27 | Athens Banner-Herald

    A boy walks his new bicycle outside at Pinewoods Community in Athens, Ga., Thursday, April 27, 2017. The 30 bikes and helmets were donated to the kids in a collaboration with Academy Sports + Outdoors, Twilight, and the Athens Jaycees.

    Comment?

  9. Bartlett & Co. LLC Has $2,281,000 Position in Novo Nordisk A/SRead the original story w/Photo

    Thursday Apr 27 | IntersportsWire

    Bartlett & Co. LLC maintained its stake in shares of Novo Nordisk A/S during the first quarter, according to its most recent 13F filing with the SEC.

    Comment?

  10. Novo Nordisk A/S Receives FDA Approval Of Saxenda (Liraglutide)...Read the original story

    Wednesday Apr 26 | BioSpace

    Novo Nordisk A/S Receives FDA Approval Of Saxenda Injection 3 Mg Label Update Including Long-Term Safety And Efficacy Data From 3-Year Trial /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration approved an updated product label for Saxenda injection 3 mg, including data showing that approximately half of patients on Saxenda who lost more than or equal to 5% of their weight after 56 weeks maintained their weight loss for 3 years. Study participants were adults with obesity or excess weight with at least one weight related comorbidity, on a reduced calorie meal plan and increased physical activity.

    Comment?

  11. River Road Asset Management LLC Takes Position in Novo Nordisk A/SRead the original story w/Photo

    Wednesday Apr 26 | Daily Political

    River Road Asset Management LLC bought a new position in shares of Novo Nordisk A/S during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor bought 556,581 shares of the company's stock, valued at approximately $19,080,000.

    Comment?

  12. 7 Undervalued Stocks That Are Set to GrowRead the original story w/Photo

    Wednesday Apr 26 | GuruFocus.com

    According to the GuruFocus All-in-One Screener , several gurus are focusing on stocks whose Peter Lynch fair values are far above the current prices. The following stocks are trading with wide margins of safety and have positive performances over the past 12 months.

    Comment?

  13. FVD, COMT: Big ETF InflowsRead the original story

    Wednesday Apr 26 | MarketNewsVideo

    Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the First Trust Value Line Dividend Index Fund , which added 5,850,000 units, or a 5.0% increase week over week. Among the largest underlying components of FVD, in morning trading today Novo Nordisk is up about 0.9%, and Public Storage is lower by about 0.6%.

    Comment?

  14. Eli Lilly: Key Q1 2017 InsightsRead the original story w/Photo

    Wednesday Apr 26 | Seeking Alpha

    With the stock still trading at premium to peers, some evidence of earnings upgrade over the coming quarters will be needed to drive the stock higher from here. Yesterday, Eli Lilly reported better than expected Q1/2017 results in terms of EPS, thanks to some manufacturing efficiencies impacting positively at gross margin level.

    Comment?

  15. [Opinion] Let's not put European public health at riskRead the original story w/Photo

    Wednesday Apr 26 | EUobserver

    Brexit brings many challenges to Europe, but only one element stands to seriously endanger European public health: The relocation of the European Medicines Agency . When it comes to ensuring public health and patient safety, or fostering innovation that leads to jobs and growth, EMA has set the standard on how to deal with approving new medicines and the surveillance of medicines that are already on the market.

    Comment?

  16. Novo Nordisk A/S (NVO) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Wednesday Apr 26 | The Breeze

    According to Zacks, "Novo Nordisk faces generic threat for several of its products as well as patent expiration issues. We are also concerned about the company's insulin product prices that are either subsidized or subject to price control.

    Comment?

  17. Zacks Investment Research Upgrades Novo Nordisk A/S (NVO) to HoldRead the original story w/Photo

    Tuesday Apr 25 | AmericanBankingNews.com

    According to Zacks, "Novo Nordisk faces generic threat for several of its products as well as patent expiration issues. We are also concerned about the company's insulin product prices that are either subsidized or subject to price control.

    Comment?

  18. GW Henssler & Associates Ltd. Has $4.012 Million Position in Novo Nordisk A/SRead the original story w/Photo

    Monday Apr 24 | Daily Political

    GW Henssler & Associates Ltd. increased its stake in shares of Novo Nordisk A/S by 12.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm owned 117,048 shares of the company's stock after buying an additional 12,595 shares during the period.

    Comment?

  19. Insulin Pen Market Expected to Reach $12 Billion by 2022Read the original story w/Photo

    Monday Apr 24 | SBWire

    Global Insulin Pen Industry Latest Report on Insulin Pen Market Global Analysis & 2022 Forecast Research Study Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.

    Comment?

  20. Novo Nordisk A/S (NVO) Given Daily Coverage Optimism Score of -0.14Read the original story w/Photo

    Monday Apr 24 | AmericanBankingNews.com

    News articles about Novo Nordisk A/S have trended somewhat negative on Monday, according to Alpha One Sentiment Analysis. The research firm, a subsidiary of Accern, identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time.

    Comment?